ST. LOUIS and INDIANAPOLIS, Dec. 1 /PRNewswire-FirstCall/ — Express Scripts, Inc. (Nasdaq: ESRX), and WellPoint, Inc. (NYSE: WLP), announced today the closing of Express Scripts’ acquisition of WellPoint’s NextRx subsidiaries. The transaction includes a 10-year agreement under which Express Scripts,... (Continue reading)